SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 1995.
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from N/A to N/A
Commission file number 0-12984
ADVANCED TOBACCO PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
TEXAS 74-2285214
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
16607 Blanco Road, Suite 1504, San Antonio, Texas 78232
(Address of principal executive offices) (Zip Code)
(210) 408-7077
(Registrant's telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed
since last report)
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Yes X No
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13 or
15(d) of the Securities Exchange Act of 1934 subsequent to the
distribution of securities under a plan confirmed by a court.
Yes No N/A
Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date:
7,792,136 as of September 30, 1995
NOTES TO FINANCIAL STATEMENTS
1. The condensed financial statements included herein were
prepared by the Company without audit. Certain information and
footnote disclosures normally included in financial statements have
been omitted. The condensed financial statements should be read in
conjunction with the financial statements and the notes thereto
included in the Company's Annual Report on Form 10-K as of June 30,
1995.
Item 2: Management's Discussion and Analysis of Financial
Condition and Results of Operation
RESULTS OF OPERATIONS
In 1987, the Company sold all of its nicotine technology to
entities owned or controlled by Pharmacia AB ("Pharmacia"), a
worldwide pharmaceutical company headquartered in Sweden that
manufactured the Nicorette chewing gum and the nicotine transdermal
patch.
Since 1987, the Company has worked jointly with Pharmacia to
develop a nicotine vaporizer product for smoking cessation which
commenced clinical and pivotal trials in late 1990. During the
fiscal year 1994, Pharmacia filed new drug applications (NDA's)
with the respective regulatory agencies in several major European
countries. After including additional data in the filing which
Pharmacia believes will facilitate the United States Food and Drug
Administration (FDA) review process, Pharmacia has indicated to the
Company that it now intends to file an NDA with the FDA during the
last quarter of calendar year 1995.
During the three-month period ended September 30, 1995, the
Company's only source of revenues has been from interest income.
LIQUIDITY AND CAPITAL RESOURCES
Cash resources, including investments, available on
September 30, 1995, were approximately $1,340,020, as compared to
approximately $1,337,366 for September 30, 1994.
COMPARISON OF SELECTED FINANCIAL DATA
Interest income for the three-month period ended September 30,
1995 increased to $19,866 as compared to $11,982 for the three-
month period ended September 30, 1994.
The Company experienced a net loss for the three-month period ended
September 30, 1995 of ($21,314) compared to a net loss of
($14,769) for the three-month period ended September 30, 1994. The
increased loss was due primarily to increased general and
administrative expenses.
General and administrative expenses were $41,180 for the
three-month period ended September 30, 1995, compared to $26,751
for the three-month period ended September 30, 1994. This increase
in general and administrative expenses was due primarily to the
payent of the Company's $10,000 license maintenance fee to Duke
University in the first quarter instead of the second quarter as
inthe prior year.
PART II - OTHER INFORMATION
Item 1: Legal Proceedings
None
Item 2: Changes in Securities
None
Item 3: Defaults Upon Senior Securities
None
Item 4: Submission of Matters to a Vote of Security Holders
None
Item 5: Other Information
None
Item 6: Exhibits and Reports on Form 8-K
None
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
ADVANCED TOBACCO PRODUCTS, INC.
(Registrant)
Dated: November 14, 1995
By: J. W. Linehan
J.W. Linehan, President and
Chief Financial Officer
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM UNAUDITED
QUARTERLY FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-1995
<PERIOD-END> SEP-30-1995
<CASH> 44,117
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 365,019
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 1,495,978
<CURRENT-LIABILITIES> 40,866
<BONDS> 0
<COMMON> 0
0
0
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 1,495,978
<SALES> 0
<TOTAL-REVENUES> 19,866
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 41,180
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (21,314)
<EPS-PRIMARY> (.002)
<EPS-DILUTED> 0
</TABLE>
